Market Trends Toward New Normal in Sykes Enterpris
Post# of 301275
NEW YORK, Aug. 31, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Sykes Enterprises, Incorporated (NASDAQ: SYKE ), Carnival Corporation (NYSE: CCL ), Covenant Transportation Group, Inc. (NASDAQ: CVTI ), Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP ), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ), and Minerals Technologies Inc. (NYSE: MTX ), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
SYKE DOWNLOAD: http://Fundamental-Markets.com/register/?so=SYKE CCL DOWNLOAD: http://Fundamental-Markets.com/register/?so=CCL CVTI DOWNLOAD: http://Fundamental-Markets.com/register/?so=CVTI SGYP DOWNLOAD: http://Fundamental-Markets.com/register/?so=SGYP REGN DOWNLOAD: http://Fundamental-Markets.com/register/?so=REGN MTX DOWNLOAD: http://Fundamental-Markets.com/register/?so=MTX
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Sykes Enterprises, Incorporated (NASDAQ: SYKE ), Carnival Corporation (NYSE: CCL ), Covenant Transportation Group, Inc. (NASDAQ: CVTI ), Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP ), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ), and Minerals Technologies Inc. (NYSE: MTX ) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed August 29th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
Sykes Enterprises, Incorporated (SYKE) REPORT OVERVIEW
Sykes Enterprises' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Sykes Enterprises reported revenue of $396.79MM vs $375.44MM (up 5.69%) and basic earnings per share $0.17 vs $0.21 (down 19.05%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Sykes Enterprises reported revenue of $1,586.01MM vs $1,460.04MM (up 8.63%) and basic earnings per share $0.77 vs $1.49 (down 48.32%). Sykes Enterprises is expected to report earnings on November 5th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.62. The estimated EPS forecast for the next fiscal year is $2.28 and is expected to report on February 25th, 2019.
To read the full Sykes Enterprises, Incorporated (SYKE) report, download it here: http://Fundamental-Markets.com/register/?so=SYKE
-----------------------------------------
Carnival Corporation (CCL) REPORT OVERVIEW
Carnival's Recent Financial Performance
For the three months ended May 31st, 2018 vs May 31st, 2017, Carnival reported revenue of $4,357.00MM vs $3,945.00MM (up 10.44%) and basic earnings per share $0.79 vs $0.52 (up 51.92%). For the twelve months ended November 30th, 2017 vs November 30th, 2016, Carnival reported revenue of $17,510.00MM vs $16,389.00MM (up 6.84%) and basic earnings per share $3.61 vs $3.73 (down 3.22%). Carnival is expected to report earnings on September 25th, 2018. The report will be for the fiscal period ending August 31st, 2018. The reported EPS for the same quarter last year was $2.29. The estimated EPS forecast for the next fiscal year is $4.85 and is expected to report on December 18th, 2018.
To read the full Carnival Corporation (CCL) report, download it here: http://Fundamental-Markets.com/register/?so=CCL
-----------------------------------------
Covenant Transportation Group, Inc. (CVTI) REPORT OVERVIEW
Covenant Transportation Group's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Covenant Transportation Group reported revenue of $196.32MM vs $164.33MM (up 19.47%) and basic earnings per share $0.54 vs $0.08 (up 575.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Covenant Transportation Group reported revenue of $705.01MM vs $670.65MM (up 5.12%) and basic earnings per share $3.03 vs $0.93 (up 225.81%). Covenant Transportation Group is expected to report earnings on October 18th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.25. The estimated EPS forecast for the next fiscal year is $2.61 and is expected to report on February 4th, 2019.
To read the full Covenant Transportation Group, Inc. (CVTI) report, download it here: http://Fundamental-Markets.com/register/?so=CVTI
-----------------------------------------
Synergy Pharmaceuticals, Inc. (SGYP) REPORT OVERVIEW
Synergy Pharmaceuticals' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Synergy Pharmaceuticals reported revenue of $12.25MM vs $2.31MM (up 429.56%) and basic earnings per share -$0.12 vs -$0.33. Synergy Pharmaceuticals is expected to report earnings on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.22. The estimated EPS forecast for the next fiscal year is -$0.31 and is expected to report on March 7th, 2019.
To read the full Synergy Pharmaceuticals, Inc. (SGYP) report, download it here: http://Fundamental-Markets.com/register/?so=SGYP
-----------------------------------------
Regeneron Pharmaceuticals, Inc. (REGN) REPORT OVERVIEW
Regeneron Pharmaceuticals' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Regeneron Pharmaceuticals reported revenue of $1,608.02MM vs $1,470.12MM (up 9.38%) and basic earnings per share $5.12 vs $3.66 (up 39.89%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Regeneron Pharmaceuticals reported revenue of $5,872.23MM vs $4,860.43MM (up 20.82%) and basic earnings per share $11.27 vs $8.55 (up 31.81%). Regeneron Pharmaceuticals is expected to report earnings on November 14th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $3.32. The estimated EPS forecast for the next fiscal year is $18.64 and is expected to report on February 14th, 2019.
To read the full Regeneron Pharmaceuticals, Inc. (REGN) report, download it here: http://Fundamental-Markets.com/register/?so=REGN
-----------------------------------------
Minerals Technologies Inc. (MTX) REPORT OVERVIEW
Minerals Technologies' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Minerals Technologies reported revenue of $464.70MM vs $414.10MM (up 12.22%) and basic earnings per share $1.25 vs $1.23 (up 1.63%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Minerals Technologies reported revenue of $1,675.70MM vs $1,638.00MM (up 2.30%) and basic earnings per share $5.54 vs $3.82 (up 45.03%). Minerals Technologies is expected to report earnings on November 1st, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $1.19. The estimated EPS forecast for the next fiscal year is $5.36 and is expected to report on February 7th, 2019.
To read the full Minerals Technologies Inc. (MTX) report, download it here: http://Fundamental-Markets.com/register/?so=MTX
-----------------------------------------
ABOUT Fundamental Markets
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.